The American Society of Nephrology's "Technology Roadmap for Innovative Approaches to Renal Replacement Therapy" aims to spark new ideas about how to treat kidney disease beyond dialysis. The roadmap lays out specific goals for therapy improvements, suggested time horizons, and the kinds of multidisciplinary collaborations required to make those improvements happen.
The Department of Health and Human Services and the American Society of Nephrology launched a $2.65 million challenge to seek better treatments for kidney disease. The program, called the KidneyX Innovation Accelerator, was launched at the American Society of Nephrology's annual meeting in San Diego.
In the fight against kidney disease, this is our moment as a community to look beyond the status quo and cynics and imagine the possible. The time is now to say "If not us, then who? And if not now, then when?"
Mark D. Okusa, MD, FASN, President of the American Society of Nephrology, catalogues the need for innovation in nephrology and the potential of KidneyX to accelerate the development and commercialization of kidney therapeutics and improve the lives of patients with kidney diseases.
Innovation in kidney care promises to be a significant theme in the kidney community in 2018, and it is hoped, well beyond.
The Department of Health and Human Services (HHS) has recently taken a critical step that will hopefully increase kidney disease research and therapy integration to the level it needs to be.
The Department of Health and Human Services announced last week that it will establish a public-private fund to help move new technology forward in treating kidney disease.
In February of 2017, the VA and ASN convened the inaugural Kidney Innovation Summit at the BAH Innovation Center in Washington D.C. to identify opportunities for innovation in the care of people with CKD.
The Kidney Innovation Summit, convened by the VA Center for Innovation and ASN, brought together over 150 great minds to think through new approaches to prevent and treat kidney disease.
